Scientists launch trial to make ageing immune cells young again
EurekAlert! - 17-Jun-2026New treatment aims to improve the body's natural defences
Join the club for FREE to access the whole archive and other member benefits.
New treatment aims to improve the body's natural defences
A major new investment will help the anti-ageing biotech test whether old cells can be partly reset to treat age-related illness
Making aging optional will require collaboration at every level of society
Pandorum Technologies secures new funding to develop “programmable” treatments that could repair damaged eyes and other organs
Why the organisation is cutting jobs to focus on using artificial intelligence to tackle disease
Life Biosciences will test a powerful gene-based treatment for glaucoma, marking the first attempt to partially reverse ageing in people
DeepMind's AlphaGenome predicts how DNA mutations affect human health
Merge Labs is developing a non-invasive brain-computer interface
Biobeat secures $50 million to expand its cuffless technology
Clinical trial will test whether damaged retinal cells can be replaced
UK biotech aims to bring eye therapy from the operating theatre to the clinic
TV and online restrictions target foods high in fat, salt and sugar
Andrew Scott is recognised for shaping global thinking on ageing, work and longer lives
New therapies aim to reset ageing cells by reprogramming how genes are switched on and off
Experimental drugs safely boost calorie burning by making cells waste a little energy as heat
Novo Nordisk’s tablet matches injection-level weight loss and could widen patient access
Blood proteins reveal organ-by-organ aging, with brain age strongly predicting disease and death
Scientists explore drugs and lifestyle changes that tame harmful aging cells to extend healthspan
Lords warn poor planning today will force younger people to work longer and save earlier
DNA from Ice Age hunter-gatherers may raise the chances of reaching extreme old age
New funding gives the regenerative biotech breathing space to prioritise placental cell therapies
New funding backs glycan biomarkers to help doctors track inflammation and biological age
Combining repair therapies in mice could redefine how science tackles aging itself
mRNA signals revived T-cell responses and improved vaccine and cancer therapy outcomes in old mice
A new perfusion machine could keep donor organs viable far longer, reshaping transplants